Monoclonal Antibodies Recognizing HIV-1 gp41 Could Inhibit Env-Mediated Syncytium Formation

被引：1
|
作者：
张耿
陈应华
机构：
[1] Protein Science Laboratory of the Ministry of Education, Tsinghua University, Beijing 100084, China
[2] Laboratory of Immunology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China ,Laboratory of Immunology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
来源：
Tsinghua Science and Technology | 2005年 / 04期
基金：
中国国家自然科学基金;
关键词：
HIV-1; monoclonal antibody; cell fusion;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Some monoclonal antibodies (mAbs) could inhibit infection by HIV-1. In this study, four mAbs against HIV-1 gp41 were prepared in mice. All four mAbs could bind to the recombinant soluble gp41 and recognize the native envelope glycoprotein gp160 expressed on the HIV-Env+ CHO-WT cell in flow cytometry analysis. Interestingly, the results show that all four mAbs purified by affinity chromatography could inhibit HIV-1 Env-mediated membrane fusion (syncytium formation) by 40%-60% at 10 μg/mL, which implies potential inhibitory activities against HIV-1.
引用
收藏
页码：512 / 516
页数：5
相关论文
共 50 条
  • [31] HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions
    Hollingsworth, Louis R.
    Lemkul, Justin A.
    Bevan, David R.
    Brown, Anne M.
    BIOPHYSICAL JOURNAL, 2018, 115 (01) : 84 - 94
  • [32] Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization
    Kim, Arthur S.
    Leaman, Daniel P.
    Zwick, Michael B.
    PLOS PATHOGENS, 2014, 10 (07)
  • [33] The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies
    Peachman, Kristina K.
    Wieczorek, Lindsay
    Polonis, Victoria R.
    Alving, Carl R.
    Rao, Mangala
    VIROLOGY, 2010, 408 (02) : 213 - 223
  • [34] HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
    Verkoczy, Laurent
    Kelsoe, Garnett
    Haynes, Barton F.
    PLOS PATHOGENS, 2014, 10 (05)
  • [35] Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
    Caillat, Christophe
    Guilligay, Delphine
    Torralba, Johana
    Friedrich, Nikolas
    Nieva, Jose L.
    Trkola, Alexandra
    Chipot, Christophe J.
    Dehez, Francois L.
    Weissenhorn, Winfried
    ELIFE, 2021, 10
  • [36] HIV-1 gp41 and gp160 are hyperthermostable proteins in a mesophilic environment - Characterization of gp41 mutants
    Krell, T
    Greco, F
    Engel, O
    Dubayle, J
    Dubayle, J
    Kennel, A
    Charloteaux, B
    Brasseur, R
    Chevalier, M
    Sodoyer, R
    El Habib, R
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (08): : 1566 - 1579
  • [37] HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
    Pan, Chungen
    Liu, Shuwen
    Jiang, Shibo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (02) : 94 - 105
  • [38] Biological function of HIV-1 transmembrane protein gp41 - A study on a putative cellular receptor of gp41
    Chen, YH
    Dierich, MP
    CHINESE SCIENCE BULLETIN, 1998, 43 (19): : 1630 - 1635
  • [39] Biological function of HIV-1 transmembrane protein gp41──A study on a putative cellular receptor of gp41
    ManfredP.Dierich
    Chinese Science Bulletin, 1998, (19) : 1630 - 1635
  • [40] Trilobatin as an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope
    Yin, Shuwen
    Zhang, Xuanxuan
    Lai, Fangyuan
    Liang, Taizhen
    Wen, Jiayong
    Lin, Wanying
    Qiu, Jiayin
    Liu, Shuwen
    Li, Lin
    FEBS LETTERS, 2018, 592 (13) : 2361 - 2377
12345